A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
JOIN AIDSMEDS YouTube
Am I Infected?
(A Guide to Testing for HIV)
en español

Introduction

Getting tested for HIV is a smart thing to do. Yet many people refuse to get tested. They find the idea of getting tested so frightening they just don't want to do it, even though they will often continue to be stressed and worried about whether they're infected. Others think of testing as unnecessary because they believe, or want to believe, that HIV is something that won't touch them.

Many times when someone gets tested, they happily find out their concern about being infected was unfounded. Getting the assurance of that negative test result can provide an enormous relief. It can also increase the motivation to take actions to stay negative. For others, getting tested and learning they are HIV positive is the first important step towards staying healthy.

The U.S. Centers for Disease Control (CDC) estimates there are about 1.1 million HIV-positive people in the United States. Of that number, the CDC estimates one in five (21 percent) are unaware of their HIV status. Often healthy in appearance and feeling well, they aren't receiving proper health care. Being unaware of their HIV status also makes it more likely they will unknowingly pass the HIV virus to others.

One of the most basic truths about HIV is that gender, age, race and economic status are irrelevant when it comes to vulnerability to HIV. Anyone can become infected. The HIV epidemic is going to be with us for a long time to come. At present there is no cure for HIV/AIDS, but there are medications that have proven to be very effective in keeping HIV-positive people alive longer and healthier.

Because knowing your accurate HIV status is essential to your good health, HIV testing is something everyone needs to know about.


next

Last Revised: July 03, 2012

This content is written by the editorial team at AIDSmeds.com.
Please find profiles of this team on our "About Us" page.

TREATMENT NEWS
Prevention updates
U.K. Throws Weight Behind Treatment as Prevention Model

Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples

Interim PrEP Recs Now Available for At-Risk Heterosexuals

Novel Vaginal HIV Microbicide Ring Enters Large-Scale Clinical Trial

What Do U.S. Women at Risk for HIV Think About PrEP?

Engagement in U.S. HIV Care: Problem Even Worse Among Blacks, Young People

CDC Data Links Poor Viral Load Suppression to Increased HIV Risk Among Black MSM

U.S. Tops List of Global HIV-Criminalization Hot-Spots

High Viral Loads Linked to HIV Risk Among Black MSM

Behavioral Factors Don't Explain Disproportionate HIV Epidemic Among Black MSM

Turning the Tide of HIV for MSM, Sex Workers and Trans People

Young Black MSM Acquiring HIV at Three Times the Rate of White MSM

‘Substantial Minority’ of MSM Would Use Condoms Less When on PrEP

MSM Able to Use Home HIV Tests to Screen Sex Partners and Lower Risk

International AIDS Experts: Meeting Today’s HIV Challenge

Test-and-Treat Has Cost Versus Benefit Considerations

Criminalizing Condom Possession Puts Sex Workers at Risk

U.S. Accomplishments, Future Endeavors, Focus of Sebelius AIDS 2012 Welcome Comments

AIDS 2012 Opener: Collaboration is Key to an 'AIDS-Free Generation'

Fauci, Wilson, Clinton: Moving Towards an 'AIDS-Free Generation'

Hillary Clinton Backs Demand for AIDS-Free Generation Blueprint

HPTN 052 Follow Up: No Increase in Unsafe Sex; Continued Viral Suppression

Ending AIDS: AVAC, amfAR Outline Key Interventions, Priorities

HIV Testing Initiatives Work: The Bronx Experience

FDA Approves In-Home, Do-It-Yourself Rapid HIV Test

New HIV Diagnoses Among Latinos Decline in U.S.

Truvada HIV PrEP Approval Decision Delayed Three Months

Adherence Challenges in Intermittent HIV PrEP Study

Sperm Washing Fertility Treatment Not Necessary: U.K. HIV Draft Guidelines

Rectal Microbicide Shows Better Safety in Laboratory Study

Orasure In-Home HIV Test Gets Unanimous Approval Recommendation

Truvada Receives PrEP Approval Recommendation

Three Big HIV Days in May at the FDA

Isentress Plus Truvada Is Safe, Potentially Effective as HIV PEP Regimen

HIV Vaccine Study Offers Up Possible Antibody Protection Clues

Undetectable Viral Load? Not Necessarily in Semen

Poor Adherence Crippled PrEP Efficacy in Women’s Study

Partners PrEP: Up to 90% Fewer Infections in Mixed-Status Hetero Couples


> More Treatment News

Search for news stories about this topic

Lesson Index
Collapse All | Up One Level

TALK TO US
Tell us what you think
Poll
Have you visited your health care provider within the last 4 months?
Yes
No


Survey
The Power of Prevention

more surveys
[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2013 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.